Randomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: Results at 18 months

Journal of Endourology

Volumn 17, Issue 2, 2003, Pages 103-107

  Cimentepe, Ersin ^a   Unsal, Ali ^a   Saglam, Remzi ^a  

^a FATIH UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ERECTILE DYSFUNCTION; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESIDUAL URINE; RETROGRADE EJACULATION; SURGICAL TECHNIQUE; TRANSURETHRAL NEEDLE ABLATION; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URETHRA STENOSIS; URINE FLOW RATE; URINE INCONTINENCE;

EID: 0037344232     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/08927790360587432     Document Type: Article

References (21)

1. Rosette JJ de la, de Wildt MJ, Hofner K, et al. High-energy thermotherapy in the treatment of benign prostatic hyperplasia: Result of the European BPH Study Group. J Urol 1996;156:97-102.
2. Bihrle R, Foster RS, Sanghvi NT, et al. High-intensity focused ultrasound for the treatment of benign prostatic hyperplasia: Early United States clinical experience. J Urol 1994;151:1271-1275.
3. Muschter R, Hofstetter A. Technique and results of interstitial laser coagulation. World J Urol 1995;13:109-114.
4. Issa MM, Myrick SE, Symbas NP. The TUNA procedure for BPH II: Basic procedure and clinical results. Infect Urol 1998;11:148-154.
5. Schulmann CC, Zlotta AR, Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: Early clinical experience. Urology 1995;45:28-33.
6. Issa MM. Transurethral needle ablation of the prostate: Report of initial United States clinical trial. J Urol 1996;156:413-419.
7. Ramon J, Lynch TH, Eardley I, et al. Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: A collaborative multicenter study. Br J Urol 1997;80:128-135.
8. Zlotta AR, Raviv G, Peny MO, et al. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: A neurohistochemical study. J Urol 1997;157:894-899.
9. Issa MM, Perez-Brayfield M, Petros JA, et al. A prospective study of transperineal prostatic block for transurethral needle ablation for benign prostatic hyperplasia: The Emory University experience. J Urol 1999;162:1636-1639.
10. Plentka L, Loghem JV, Hahn E, et al. Comorbidities and perioperative complications among patients with surgically treated benign prostatic hyperplasia. Urology 1991;38(suppl 1):43.
11. Mebust WK, Holtgrewe HL, Cockett ATK, et al. Transurethral prostatectomy: Immediate and postoperative complications: A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 1989;141:243-247.
12. Goldwasser B, Ramon J, Engleberg S, et al. Transurethral needle ablation (TUNA) of the prostate using low-level radiofrequency energy: An animal experimental study. Eur Urol 1993;24:400-405.
13. Ramon J, Goldwasser B, Shenfeld O, et al. Needle ablation using radiofrequency current as a treatment for benign prostatic hyperplasia: Experimental results in ex-vivo human prostate. Eur Urol 1993;24:406-410.
14. Bruskewitz R, Issa MM, Roehrborn CG, et al. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 1998;159:1588-1593.
15. Schatzl G, Madersbacher S, Djavan B, et al. Two-year results of transurethral resection of the prostate versus four "less invasive" treatment options. Eur Urol 2000;37:695-701.
16. Barry MJ, Coffey DC, Fitzpatrick J, et al. Recommendations of the International Consensus Committee concerning patient evaluation for research studies. In: Cockett ATK, Aso Y, Chatelain C, et al (eds): Proceeding of the International Consultation on Benign Prostatic Hyperplasia (BPH). Paris, Channel Islands: Scientific Communication International, 1991, pp 279-281.
17. Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of an abridged, 5 items version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impotence Res 1999;11:319-326.
18. Razor JS, Zlotta AR, Edwards SD, et al. Transurethral needle ablation (TUNA): Thermal gradient mapping and comparison of lesion size in a tissue model and in patients with benign prostatic hyperplasia. Eur Urol 1993;24:411-414.
19. Harewood LM, Cleeve KL, O'Connell HE, et al. Transurethral needle ablation of the prostate (TUNA): Clinical results and ultrasound, endoscopic, and histologic findings in pilot study of patients in urinary retention. J Endourol 1995;9:407-412.
20. Campo B, Bergamaschi F, Corrada P, et al. Transurethral needle ablation (TUNA) of the prostate: A clinical and urodynamic evaluation. Urology 1997;49:847-850.
21. Zlotta A, Schulman C, Giannakopoulos X, et al. Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of benign prostatic hyperplasia (BPH): Clinical outcome after 5 years [abstract 507]. Eur Urol 2002;41(suppl 1).